Healthcare Services

A significant industry trend in the Bleeding Disorder Testing Market includes the Innovative Gene Therapy Advancements In Bleeding Disorder Treatment Market

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Bleeding Disorder Testing Market From 2026 To 2030?

The bleeding disorder testing market size has experienced robust growth in recent years. This market is projected to expand from $16.18 billion in 2025 to $17.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. Historically, this expansion has been driven by factors such as the increasing occurrence of inherited bleeding disorders, the broader utilization of laboratory diagnostics, the widespread availability of coagulation analyzers, the expansion of hospital diagnostic services, and heightened clinical awareness regarding bleeding disorders.

The bleeding disorder testing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $23.54 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%. This projected growth is driven by factors such as a heightened need for swift diagnostic options, the broader application of personalized medicine, increased investment in automated diagnostics, the growing popularity of point-of-care testing, and the incorporation of AI-powered diagnostic analytics. Key trends anticipated during this period encompass improvements in the precision of coagulation testing, wider utilization of point-of-care diagnostic tools, an increase in the deployment of automated blood analyzers, the expansion of genetic testing specifically for bleeding disorders, and improved integration of digital laboratory systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18263&type=smp

What Major Drivers Are Influencing Demand In The Bleeding Disorder Testing Market?

The expanding volume of clinical trials is anticipated to drive the future expansion of the bleeding disorder testing market. These trials are research endeavors evaluating the safety and effectiveness of new medical treatments, therapies, medications, or technologies for human use. The rise in clinical trials stems from progress in medical research, increased funding for healthcare innovation, and a growing need for novel treatments and therapies. In clinical trials, bleeding disorder testing serves to evaluate the effectiveness and safety of emerging medications and treatments for bleeding disorders, gauge their success in managing or correcting clotting irregularities, and track patient reactions to ensure optimal dosage and efficacy. For example, as reported by ClinicalTrials.gov, a US-based clinical trial registry, approximately 477,228 clinical trials were recorded by the close of 2023, representing an increase from 437,507 in 2022. Consequently, the rising number of clinical trials is fueling the expansion of the bleeding disorder testing market.

Which Segments Are Included In The Analysis Of The Bleeding Disorder Testing Market?

The bleeding disorder testing market covered in this report is segmented –

1) By Product Type: Reagents And Consumables, Instruments

2) By Indication: Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura, Other Indications

3) By End User: Hospitals And Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Reagents And Consumables: Coagulation Reagents, Plasma And Blood Collection Consumables, Hemostasis Reagents, Factor Deficiency Assay Kits, Activated Partial Thromboplastin Time (APTT) Reagents

2) By Instruments: Coagulation Analyzers, Platelet Function Analyzers, Hemostasis Testing Instruments, Point-Of-Care Testing Devices, Automated Blood Testing Systems

Which Trends Are Influencing The Bleeding Disorder Testing Market?

Leading companies within the bleeding disorder testing market are concentrating on developing innovative products, such as gene therapy for Hemophilia B, with the goal of providing long-term solutions, curing genetic bleeding conditions, enhancing treatment outcomes, and expanding their market presence. Hemophilia B is a form of bleeding disorder characterized by a deficiency of clotting factor IX, which is essential for proper blood coagulation. Gene therapy for Hemophilia B represents an emerging treatment designed to offer a lasting solution by addressing the underlying genetic defect responsible for the condition. For instance, in February 2023, CSL Limited, an Australia-based biotechnology company, along with the European Commission, granted conditional marketing authorization (CMA) for HEMGENIX, which is the first and only one-time gene therapy for treating severe and moderately severe hemophilia B. This singular treatment aims to deliver prolonged efficacy, thereby reducing or eliminating the need for regular factor replacement therapy. HEMGENIX is notable for its pioneering gene therapy approach, providing a transformative option for patients with hemophilia B and potentially altering the standard of care in the field.

Which Key Industry Participants Are Active In The Bleeding Disorder Testing Market?

Major companies operating in the bleeding disorder testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sysmex Corporation, Diagnostica Stago, Werfen Group, Sekisui Chemical Co. Ltd., Helena Laboratories, HORIBA Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Haemonetics Corporation, QuidelOrtho Corporation, Instrumentation Laboratory, Beckman Coulter Inc., Grifols S.A., Meridian Bioscience Inc.

Read the full bleeding disorder testing market report here:

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Bleeding Disorder Testing Market?

North America was the largest region in the bleeding disorder testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bleeding Disorder Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18263&type=smp

Browse Through More Reports Similar to the Global Bleeding Disorder Testing Market 2026, By The Business Research Company

Bleeding Disorders Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Blood Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Clinical Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795